The Association for Savings and Investment South Africa (Asisa)

Loading player...
The Association for Savings and Investment South Africa (Asisa) has taken note of the most recent attempt by the South African Institute of Race Relations (IRR) to once again draw Asisa members into the prescription debate.
This seems to be a deliberate endeavor by the IRR to stir up panic amongst South African investors during a time when calm and rationality is needed more than ever.
The Association for Savings and Investment South Africa (ASISA) has taken note of the most recent attempt by the South African Institute of Race Relations (IRR) to once again draw ASISA members into the prescription debate.

Leon Campher, CEO of ASISA, says this seems to be a deliberate endeavor by the IRR to stir up panic amongst South African investors during a time when calm and rationality is needed more than ever.

Campher points out that in recent months the various social partners of the National Economic Development and Labour Council (Nedlac), namely government, labour, business and community, tabled their economic recovery plans and not a single one mentioned the prescription of assets as a possible solution.
6 Oct 2020 1PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min